On Monday, Boston Scientific Corp (NYSE: BSX) was -0.25% drop from the session before settling in for the closing price of $90.66. A 52-week range for BSX has been $53.93 – $91.93.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 8.10% over the last five years. When this article was written, the company’s average yearly earnings per share was at 20.04%. With a float of $1.47 billion, this company’s outstanding shares have now reached $1.47 billion.
The firm has a total of 48000 workers. Let’s measure their productivity. In terms of profitability, gross margin is 67.3%, operating margin of 17.33%, and the pretax margin is 13.84%.
Boston Scientific Corp (BSX) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Boston Scientific Corp stocks. The insider ownership of Boston Scientific Corp is 0.42%, while institutional ownership is 91.31%. The most recent insider transaction that took place on Nov 27 ’24, was worth 121,105. In this transaction SVP, Global Controller and CAO of this company sold 1,336 shares at a rate of $90.65, taking the stock ownership to the 2,957 shares. Before that another transaction happened on Dec 02 ’24, when Company’s Officer proposed sale 6,983 for $90.78, making the entire transaction worth $633,917.
Boston Scientific Corp (BSX) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted 0.55 earnings per share (EPS) during the time that was better than consensus figure (set at 0.51) by 0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.64 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 20.04% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 14.20% during the next five years compared to -2.05% drop over the previous five years of trading.
Boston Scientific Corp (NYSE: BSX) Trading Performance Indicators
You can see what Boston Scientific Corp (BSX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.02. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.38. Likewise, its price to free cash flow for the trailing twelve months is 61.82.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.21, a number that is poised to hit 0.65 in the next quarter and is forecasted to reach 2.79 in one year’s time.
Technical Analysis of Boston Scientific Corp (BSX)
Analysing the last 5-days average volume posted by the [Boston Scientific Corp, BSX], we can find that recorded value of 5.03 million was lower than the volume posted last year of 6.06 million. As of the previous 9 days, the stock’s Stochastic %D was 70.16%. Additionally, its Average True Range was 1.69.
During the past 100 days, Boston Scientific Corp’s (BSX) raw stochastic average was set at 92.52%, which indicates a significant increase from 74.66% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 20.94% in the past 14 days, which was higher than the 18.04% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $86.69, while its 200-day Moving Average is $77.17. Now, the first resistance to watch is $91.11. This is followed by the second major resistance level at $91.80. The third major resistance level sits at $92.25. If the price goes on to break the first support level at $89.97, it is likely to go to the next support level at $89.52. Should the price break the second support level, the third support level stands at $88.83.
Boston Scientific Corp (NYSE: BSX) Key Stats
There are 1,473,827K outstanding shares of the company, which has a market capitalization of 133.28 billion. As of now, sales total 14,240 M while income totals 1,591 M. Its latest quarter income was 4,209 M while its last quarter net income were 468,000 K.
